Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
| Actual shortage: | 226 (7%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYA | 3.00MG 0.02MG | TABLET | Resolved | 2017-03-11 | 2020-09-04 | 555 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2023-05-26 | 2023-06-02 | 193206 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2023-09-22 | 2023-10-06 | 204996 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213568 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2024-03-08 | 2024-03-15 | 221690 |
| APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2017-03-13 | 2017-03-31 | 2019 |
| APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2017-04-25 | 2018-03-14 | 7880 |
| APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2018-12-19 | 2019-03-21 | 69959 |
| APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2019-04-29 | 2019-08-22 | 82753 |
| OVIMA 21 | 30MCG 150MCG | TABLET | Resolved | 2019-08-19 | 2019-09-05 | 91923 |
| OVIMA 21 | 30MCG 150MCG | TABLET | Resolved | 2023-04-27 | 2023-05-06 | 190868 |
| OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2018-04-04 | 2018-05-03 | 44969 |
| OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2019-06-05 | 2019-09-23 | 85622 |
| OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2021-09-24 | 2021-11-15 | 146163 |
| OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2022-01-07 | 2022-02-07 | 152329 |
| OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2023-03-02 | 2023-03-23 | 185933 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3.0G 0.375G | POWDER FOR SOLUTION | Actual shortage | 2017-03-11 | 2018-09-12 | 577 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.0G 0.5G | POWDER FOR SOLUTION | Actual shortage | 2017-03-11 | 2017-10-05 | 580 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | Actual shortage | 2017-03-11 | 2018-09-12 | 583 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | Resolved | 2018-01-17 | 2018-08-22 | 36356 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
| APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |
| APO-VORICONAZOLE | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60861 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |